ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CircFGGY Inhibits Cell Growth, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma via Regulating the miR-545-3p/Smad7 Axis

Feng, Kun-Liang; Diao, Na; Zhou, Zhai-Wen; Fang, Chong-Kai; Wang, Ji-Nan; Zhang, Ying; Luo, Rui; Zhong, Chong*广州中医药大学; 中山大学; 6; 1
Frontiers in Cell and Developmental Biology2022-5-3DOI: 10.3389/fcell.2022.850708
3被引3阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Circular RNAs (circRNAs) play critical roles in the progression of HCC. However, the role of the newly identified circFGGY (hsa_circ_0006633) in the development and progression of HCC has not been explored. In this study, we found that circFGGY was significantly downregulated in tumor compared with that in adjacent normal liver tissues of patients with HCC. HCC patients with low circFGGY expression had poor overall survival after hepatectomy. Moreover, it was found that circFGGY could inhibit the proliferation, invasion and epithelial-mesenchymal transition of HCC both in vivo and in vitro. Mechanistically, circFGGY promoted the expression of Smad7, a well-known suppressor of the transforming growth factor-beta signaling pathway. In addition, miR-545-3p, a tumor promoter targeting both circFGGY and Smad7, suppressed the upregulation of Smad7 caused by circFGGY overexpression. Collectively, our data revealed that circFGGY inhibits the proliferation and invasion of HCC cells by sponging miR-545-3p and promote the expression of Smad7, indicating that circFGGY functions as a tumor suppressor and could be a prognostic biomarker for HCC.

学科与关键词

关键词
circFGGYhepatocellular carcinomamiR-545-3pSMAD7epithelial-mesenchymal transition
相关
加载中…
  • Circ_0064288 acts as an oncogene of hepatocellular carcinoma cells by inhibiting miR-335-5p expression and promoting ROCK1 expression
    Nie, Yingying; Zhu, Xuedan; Bu, Nan; Jiang, Yang; Su, Yue; Pan, Keming; Li, Shanshan*BMC CANCER, 2022, 22(1): 265.被引 1
  • Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184
    Guo, Xuan; Wang, Ziying; Deng, Xue; Lu, Yantong; Huang, Xuhui; Lin, Juze*; Lan, Xiaohe; Su, Qiao; Wang, Changjun*CELL CYCLE, 2022, 21(15): 1557-1577.被引 11
  • Targeting a novel circITCH/miR-421/BTG1 axis is effective to suppress the malignant phenotypes in hepatocellular carcinoma (HCC) cells
    Li, Xiaodong; Yin, Xuedong; Bao, Heyi; Liu, Chang*CYTOTECHNOLOGY, 2023, 75(3): 255-267.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cell and Developmental Biology
发表日期
2022-05-03
卷期
第 10 卷
页码
850708
DOI
10.3389/fcell.2022.850708
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81873303]; Natural Science Foundation of Guangdong Province, China [2019A1515011013]; Key Projects of Educational Commission of Guangdong Province, China [2019KZDXM045]; Medical innovation project of the First Affiliated Hospital of Guangzhou University of Chinese Medicine [2019?T18]; Administration of Traditional Chinese Medicine of Guangdong Province, China [20211122]; Science and Technology Planning Project of Guangzhou [202102010406]

作者

  • F

    Feng, Kun-Liang (第一作者)

    guangzhou univ chinese med · 1

  • D

    Diao, Na

    6 · sun yat sen univ

查看全部 8 位作者收起作者
  • Z

    Zhou, Zhai-Wen

    1 · guangzhou univ chinese med

  • F

    Fang, Chong-Kai

    guangzhou univ chinese med · 1

  • W

    Wang, Ji-Nan

    guangzhou univ chinese med · 1

  • Z

    Zhang, Ying

    guangzhou univ chinese med · 1

  • L

    Luo, Rui

    guangzhou univ chinese med · 1

  • Z

    Zhong, Chong (通讯)

    guangzhou univ chinese med · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417